HomeQuestion

How would you manage persistent severe neutropenia from obinutuzumab in a 1st line CLL patient prior to venetoclax initiation?

1

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

For patients with newly diagnosed unmutated CLL how will you decide between BTKi alone vs Ven/BTKi vs Ven/Obin vs Ven/Obin/Acalabrutinib?

How do you treat patients with T-cell ALL/T-cell lymphoblastic lymphoma who have pre-existing CKD with a CrCl of 30 mL/min or less?

What induction regimen would you consider for KMT2A-rearranged AML in a young patient with multiple medical co-morbidities who is ineligible for clinical trials?

How would you treat AML in a pregnant patient at 12 weeks' gestation?

In patients with Stage 0 CLL, who are clinically doing well and don't warrant treatment, do you typically obtain CLL FISH Panel and p53 status?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.